These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Younes M; Juarez D; Lechago LV; Lerner SP Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807 [TBL] [Abstract][Full Text] [Related]
4. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. Younes M; Ertan A; Lechago LV; Somoano J; Lechago J Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):303-5. PubMed ID: 9149888 [TBL] [Abstract][Full Text] [Related]
5. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403 [TBL] [Abstract][Full Text] [Related]
6. Fas ligand expression in esophageal carcinomas and their lymph node metastases. Younes M; Schwartz MR; Ertan A; Finnie D; Younes A Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Younes M; Lechago LV; Lechago J Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281 [TBL] [Abstract][Full Text] [Related]
8. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma]. Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832 [TBL] [Abstract][Full Text] [Related]
10. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975 [TBL] [Abstract][Full Text] [Related]
11. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma]. Liu AJ; Hou N; Chen LZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086 [TBL] [Abstract][Full Text] [Related]
12. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885 [TBL] [Abstract][Full Text] [Related]
13. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma. Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H Oncology; 2009; 76(4):286-92. PubMed ID: 19262068 [TBL] [Abstract][Full Text] [Related]
14. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091 [TBL] [Abstract][Full Text] [Related]
15. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization. Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688 [TBL] [Abstract][Full Text] [Related]
16. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596 [TBL] [Abstract][Full Text] [Related]
17. [Expression of annexin I in different histological types of carcinomas]. Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060 [TBL] [Abstract][Full Text] [Related]
20. Expression of the GLUT1 glucose transporter in gallbladder carcinomas. Kim YW; Park YK; Yoon TY; Lee SM Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]